EIF5A2 and prostate cancer: Expression of EIF5A2 also predicts poor prognosis of nasopharyngeal carcinoma patients [96], prostate cancer patients [97], and upper tract urothelial carcinoma patients [98], however the exact functions of eIF5A2 in these cancers should be further studied.